Fujifilm Wants to Launch Avigan Trial in Japan by End of This Week, Abe Talks to WHO Chief

Fujifilm Toyama Chemical plans to kick off its company-sponsored registration trial in Japan for the anti-flu agent Avigan (favipiravir) by the end of the week at the earliest for the treatment of the novel coronavirus disease COVID-19, a company official...read more